Matches in Ubergraph for { <https://frink.apps.renci.org/.well-known/genid/B7badfedda7b04a0aaf88cfe0f03ff56e> ?p ?o ?g. }
Showing items 1 to 5 of
5
with 100 items per page.
- B7badfedda7b04a0aaf88cfe0f03ff56e NCIT_P378 "NCI" @default.
- B7badfedda7b04a0aaf88cfe0f03ff56e type Axiom @default.
- B7badfedda7b04a0aaf88cfe0f03ff56e annotatedProperty IAO_0000115 @default.
- B7badfedda7b04a0aaf88cfe0f03ff56e annotatedSource NCIT_C173001 @default.
- B7badfedda7b04a0aaf88cfe0f03ff56e annotatedTarget "The unique identifier assigned to the arm of the Molecular Analysis for Therapy Choice (MATCH) phase II clinical trial that is investigating treatment with trastuzumab and pertuzumab in patients with cancers that have ERBB2 (HER2) amplifications, excluding breast cancers, colorectal cancers, gastric cancers and gastroesophageal junction (GEJ) cancers." @default.